HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dirk Reinhardt Selected Research

ICE protocol 4

8/2015Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.
1/2012The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.
6/2010Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
5/2010Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse.
9/2006Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
11/2004Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dirk Reinhardt Research Topics

Disease

48Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2023 - 05/2003
34Neoplasms (Cancer)
01/2024 - 01/2002
22Leukemia
12/2023 - 04/2003
9Down Syndrome (Down's Syndrome)
10/2018 - 02/2006
8Myeloid Leukemia (Leukemia, Myelocytic)
10/2023 - 11/2006
6Cardiotoxicity
12/2018 - 01/2002
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 11/2005
5Infections
10/2016 - 11/2004
4Residual Neoplasm
01/2020 - 01/2002
4Acute Promyelocytic Leukemia
12/2017 - 05/2003
3Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)
01/2022 - 02/2006
3Cardiomyopathies (Cardiomyopathy)
12/2018 - 06/2007
3Heart Failure
06/2008 - 05/2004
2Hypoxia (Hypoxemia)
01/2024 - 02/2023
2Lymphoma (Lymphomas)
12/2023 - 07/2023
2Liver Diseases (Liver Disease)
10/2018 - 03/2008
2Chromosome Aberrations (Chromosome Abnormalities)
01/2016 - 06/2010
2Neutropenia
02/2007 - 09/2006
1Glioma (Gliomas)
01/2024
1Glioblastoma (Glioblastoma Multiforme)
01/2024
1Aneuploidy (Aneuploid)
01/2023
1Trisomy (Trisomies)
01/2023
1Osteosarcoma (Osteogenic Sarcoma)
10/2022
1Bites and Stings (Sting)
04/2022
1Hypertension (High Blood Pressure)
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Capillary Leak Syndrome
11/2021
1Neuroblastoma
11/2021
1Hypersensitivity (Allergy)
11/2021
1Fever (Fevers)
11/2021
1Pain (Aches)
11/2021
1Wilms Tumor (Wilm's Tumor)
08/2021
1Fanconi Anemia (Fanconi's Anemia)
08/2021
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2021
1Meningioma (Meningiomas)
04/2021
1Astrocytoma (Pilocytic Astrocytoma)
04/2021
1Uveal melanoma
04/2021
1Retinoblastoma (Glioblastoma, Retinal)
04/2021
1Primitive Neuroectodermal Tumors (PNET)
04/2021
1Fibrosis (Cirrhosis)
10/2020
1Sickle Cell Anemia (Hemoglobin S Disease)
03/2020
1Acute Chest Syndrome
03/2020
1Critical Illness (Critically Ill)
03/2020
1Carcinoma (Carcinomatosis)
01/2020
1Hodgkin Disease (Hodgkin's Disease)
01/2020

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
07/2023 - 02/2006
6AnthracyclinesIBA
12/2018 - 01/2002
5MicroRNAs (MicroRNA)IBA
01/2018 - 05/2012
5Daunorubicin (Cerubidine)FDA LinkGeneric
01/2018 - 11/2006
4DNA (Deoxyribonucleic Acid)IBA
04/2022 - 04/2012
4Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2006
3Protein Isoforms (Isoforms)IBA
01/2023 - 09/2007
3AntibodiesIBA
11/2021 - 01/2003
3Cytarabine (Cytosar-U)FDA LinkGeneric
10/2018 - 03/2008
3Core Binding Factors (Core-Binding Factor)IBA
11/2011 - 03/2011
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2010 - 09/2006
2RNA (Ribonucleic Acid)IBA
12/2023 - 01/2019
2Long Noncoding RNAIBA
10/2023 - 07/2014
2AntigensIBA
01/2022 - 01/2005
2Transaminases (Aminotransferases)IBA
01/2022 - 05/2003
2Gemtuzumab (Mylotarg)FDA Link
01/2019 - 05/2003
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
02/2016 - 11/2004
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2016 - 06/2006
2Histone Deacetylase InhibitorsIBA
01/2016 - 03/2003
2nuclear pore complex protein 98IBA
01/2016 - 09/2011
2Histone Deacetylases (Histone Deacetylase)IBA
01/2016 - 03/2003
2CateninsIBA
04/2014 - 04/2012
2Cytostatic AgentsIBA
01/2003 - 01/2002
1ChromatinIBA
10/2023
1Messenger RNA (mRNA)IBA
07/2023
1Oxygen (Dioxygen)IBA
02/2023
1Interleukin-15 (Interleukin 15)IBA
01/2022
1CalicheamicinsIBA
01/2022
1Inotuzumab OzogamicinIBA
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1dinutuximabIBA
11/2021
1Nonsense Codon (Nonsense Mutation)IBA
08/2021
1Retinaldehyde (Retinal)IBA
04/2021
1CytokinesIBA
10/2020
1Circulating Tumor DNAIBA
01/2020
1Cell-Free Nucleic AcidsIBA
01/2020
1BI 6727IBA
10/2019
1Biomarkers (Surrogate Marker)IBA
01/2019

Therapy/Procedure

24Therapeutics
01/2024 - 01/2002
14Drug Therapy (Chemotherapy)
01/2022 - 01/2003
6ICE protocol 4
08/2015 - 11/2004
4Hematopoietic Stem Cell Transplantation
06/2022 - 12/2017
3Investigational Therapies (Experimental Therapy)
12/2023 - 07/2013
3Immunotherapy
01/2022 - 03/2021
2Transplantation
01/2024 - 02/2023
2Stem Cell Transplantation
01/2019 - 01/2012
2Aftercare (After-Treatment)
12/2007 - 04/2003
1Palliative Care (Palliative Therapy)
02/2023
1Prostheses and Implants (Prosthesis)
10/2022
1Heterologous Transplantation (Xenotransplantation)
01/2022
1Microspheres (Microsphere)
01/2022
1Radiotherapy
11/2021
1Extracorporeal Membrane Oxygenation
03/2020
1Artificial Respiration (Mechanical Ventilation)
03/2020
1Salvage Therapy
01/2019